Eli Lilly and Company
NYSE:LLY
Sector
Location
Market Cap
USD 637.99 B
Share Price
USD 711.68
Avg Daily Volume
4,373,275
Change (1 day)
0.26%
Change (1 year)
-25.41%
Change (YTD)
-7.81%
Eli Lilly and Company Key Metrics 2015 - 2025
This table shows the Key Metrics for Eli Lilly and Company going from 2015 until 2025. Key metrics are specific quantitative measures used to assess the performance and progress of a company, often tailored to its industry and objectives, providing insights into growth, profitability, and operational efficiency.
Key Metrics
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Neurocrine Biosciences, Inc.
USD 135.43
NBIX
+0.15
0.11%
Corcept Therapeutics Incorporated
USD 70.33
CORT
-0.65
-0.92%
Jazz Pharmaceuticals plc
USD 123.11
JAZZ
+2.58
2.14%
H. Lundbeck A/S
USD 6.25
HLUN-B.CO
+0.15
2.46%
Axsome Therapeutics, Inc.
USD 118.51
AXSM
+1.37
1.17%
SK Biopharmaceuticals Co., Ltd.
USD 71.21
326030.KS
+2.10
3.04%
Alkermes plc
USD 29.75
ALKS
+0.69
2.37%
ACADIA Pharmaceuticals Inc.
USD 25.74
ACAD
+0.95
3.83%
Indivior PLC
USD 24.32
INDV
+0.27
1.12%
Supernus Pharmaceuticals, Inc.
USD 44.88
SUPN
+1.56
3.60%
Biohaven Ltd.
USD 15.61
BHVN
+0.93
6.33%
AbbVie Inc.
USD 210.60
ABBV
+1.10
0.53%
Roche Holding AG
USD 340.96
RO.SW
+1.66
0.49%
Novartis AG
USD 127.06
NOVN.SW
-0.12
-0.10%
Novo Nordisk A/S
USD 56.99
NOVO-B.CO
+1.76
3.18%